ANTI GBM (GLOMERULAR BASEMENT MEMBRANE ) IGG ANTIBODIES - EIA

The Anti-GBM (Glomerular Basement Membrane) IgG Antibodies Test by Enzyme Immunoassay (EIA) is a specialized blood test used to detect IgG autoantibodies directed against the glomerular basement membrane (GBM) of the kidneys. These autoantibodies are strongly associated with Anti-GBM Disease, also known as Goodpasture Syndrome, a rare autoimmune disorder that can affect both the kidneys and lungs.

In Anti-GBM disease, the immune system mistakenly attacks the basement membrane in the glomeruli (the kidney's filtering units) and sometimes the alveoli (air sacs) of the lungs. This immune-mediated damage may result in rapidly progressive glomerulonephritis (RPGN), kidney failure, and pulmonary hemorrhage if not diagnosed and treated promptly.

The EIA (Enzyme Immunoassay) method provides a highly sensitive and specific approach for detecting Anti-GBM IgG antibodies in the blood. Early identification allows physicians to initiate immunosuppressive therapy and plasma exchange, improving the chances of preserving kidney and lung function.

Benefits of the Test

• Detects Anti-GBM IgG autoantibodies with high accuracy
• Helps diagnose Goodpasture syndrome
• Supports early detection of autoimmune kidney disease
• Assists in evaluating rapidly progressive glomerulonephritis (RPGN)
• Helps investigate pulmonary-renal syndrome
• Supports treatment planning and monitoring
• Requires only a peripheral blood sample

Why Doctors Recommend This Test

Doctors may recommend this test if a patient has:

• Blood in the urine (hematuria)
• Protein in the urine (proteinuria)
• Rapid decline in kidney function
• Persistent swelling due to kidney disease
• Coughing up blood (hemoptysis)
• Shortness of breath with suspected pulmonary hemorrhage
• Suspected Goodpasture syndrome
• Autoimmune glomerulonephritis
• Abnormal kidney biopsy findings

Preparation Before Test

Sample Required

• Peripheral venous blood sample (Serum)

Preparation Guidelines

• No fasting is required.
• Continue medications unless otherwise advised by your physician.
• Inform your healthcare provider about any autoimmune disorders or immunosuppressive therapy.
• Follow laboratory instructions before sample collection.

Reporting Time

Results are generally available within 3–7 working days, depending on laboratory processing.

Who Should Take This Test?

This test is recommended for:

• Individuals with unexplained kidney inflammation
• Patients with rapidly progressive kidney disease
• Individuals with blood in urine and declining kidney function
• Patients with suspected Goodpasture syndrome
• Individuals with pulmonary-renal syndrome
• Patients with autoimmune kidney disorders
• Individuals referred by nephrologists, rheumatologists, or pulmonologists

Clinical Significance

A positive Anti-GBM IgG antibody result may indicate:

• Anti-GBM Disease
• Goodpasture Syndrome
• Rapidly Progressive Glomerulonephritis (RPGN)
• Autoimmune Glomerulonephritis
• Pulmonary-Renal Syndrome

Symptoms associated with Anti-GBM disease may include:

• Blood in urine
• Proteinuria
• Reduced urine output
• Swelling of the legs or face
• High blood pressure
• Fatigue
• Coughing up blood
• Shortness of breath
• Progressive kidney dysfunction

Test results should always be interpreted alongside clinical findings, kidney function tests, urinalysis, imaging studies, and, when indicated, kidney biopsy results.